MAPrc’s researchers are currently working on a number of projects investigating new treatment methods for people experiencing schizophrenia

The following projects are currently recruiting participants. Please contact us if you wish to receive futher information or take part in a project.

The Damian Project - The Use of Bazadoxifene as a Potential Treatment for Men with Schizophrenia
Thanks to the generous support of the Mohr family, and in honour of the memory of Damian Mohr, MAPrc is privileged to be able to conduct this exiciting new trial to explore the use of Bazadoxifene, a Selective Estrogen Receptor Modulator (SERM), as a potential treatment for men with Schizophrenia.  

Adjunctive SERM Hormone Treatment for Men and Women with Schizophrenia and Schizoaffective Disorder
Men and women who are 18 and over, with schizophrenia or schizoaffective disorder, are invited to take part in a 12-week adjunctive treatment study that is underway in Melbourne. Hormones are known to play a role in the expression of schizophrenia and related disorders. The Monash Alfred Psychiatry research centre is investigating whether a medication that targets hormone receptors in the brain, when taken in combination with regular antipsychotic medication, can better improve psychotic symptoms, mood and cognitive functioning. Participants will be reimbursed for their time and travel can be negotiated. For further details click here 


 MAPrc Multidisciplinary Alfred Psychiatry Research Centre, Level 4, 607 St Kilda Road, Melbourne 3004